SPHK1 and breast carcinoma: Results generated from a syngeneic breast cancer model have corroborated that inhibition of SK1 in tumor cells decreased S1P levels and lung and lymph nodes metastasis through the disruption of angiogenesis and lymphangiogenesis [24].